TRCT
SPRB

Tower Research Capital (TRC)’s Spruce Biosciences SPRB Stock Holding History

Tower Research Capital (TRC)’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
246
+106
+76% +$5.93K ﹤0.01% 3864
2026
Q1 		$9.15K Buy
140
+139
+13,900% +$9.59K ﹤0.01% 3937
2025
Q4 		$87 Buy
+1
New +$107 ﹤0.01% 5051
2025
Q2 		– Sell
-63
Closed -$1.36K – 5664
2025
Q1 		$1.36K Hold
63
– – ﹤0.01% 4724
2024
Q4 		$2K Buy
63
+1
+2% +$37 ﹤0.01% 4927
2024
Q3 		$2.21K Sell
62
-379
-86% -$13.9K ﹤0.01% 5032
2024
Q2 		$17.1K Buy
441
+289
+190% +$15.5K ﹤0.01% 3845
2024
Q1 		$8.98K Buy
+152
New +$38.7K ﹤0.01% 3921
2023
Q4 		– Sell
-58
Closed -$9.85K – 6222
2023
Q3 		$9.85K Buy
58
+27
+87% +$4.55K ﹤0.01% 4175
2023
Q2 		$5.07K Sell
31
-21
-40% -$3.51K ﹤0.01% 4867
2023
Q1 		$9K Sell
52
-94
-64% -$17.5K ﹤0.01% 4562
2022
Q4 		$12K Buy
146
+48
+49% +$4.02K ﹤0.01% 3769
2022
Q3 		$10K Buy
98
+58
+145% +$8.11K ﹤0.01% 4588
2022
Q2 		$5K Sell
40
-31
-44% -$3.97K ﹤0.01% 5119
2022
Q1 		$11K Buy
71
+5
+8% +$930 ﹤0.01% 4225
2021
Q4 		$22K Buy
66
+23
+53% +$6.85K ﹤0.01% 3577
2021
Q3 		$20K Buy
43
+31
+258% +$19.5K ﹤0.01% 3732
2021
Q2 		$10K Buy
12
+3
+33% +$3.2K ﹤0.01% 4408
2021
Q1 		$11K Buy
9
+3
+50% +$4.61K ﹤0.01% 4326
2020
Q4 		$10K Buy
+6
New +$9.95K ﹤0.01% 4331

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Tower Research Capital (TRC)'s SPRB Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Spruce Biosciences (SPRB) stake by 76% in Q2 2026, buying an estimated $5.93K and bringing the position to 246 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3864.

Tower Research Capital (TRC) first reported a position in SPRB in Q4 2020 and has held it in 20 quarters since. The position peaked at $22K in Q4 2021. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Tower Research Capital (TRC) held 246 shares of Spruce Biosciences worth $13.3K as of Q2 2026.
  • Tower Research Capital (TRC) bought 106 Spruce Biosciences shares in Q2 2026, an estimated $5.93K.
  • Spruce Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3864 holding.
  • Tower Research Capital (TRC) first reported a position in Spruce Biosciences in Q4 2020 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Spruce Biosciences position peaked at $22K in Q4 2021.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.